Grey matter changes associated with medication-overuse headache: Correlations with disease related disability and anxiety

World Journal of Biological Psychiatry

Volumn 13, Issue 7, 2012, Pages 517-525

  Riederer, Franz ^a   Marti, Marvin ^a   Luechinger, Roger ^b   Lanzenberger, Rupert ^c   Von Meyenburg, Jan ^d   Gantenbein, Andreas R ^a   Pirrotta, Roberto ^d   Gaul, Charly ^e   Kollias, Spyridon ^d   Sándor, Peter S ^a,f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f Reha Clinic   (Switzerland)

Author keywords

Anxiety; Medication overuse headache; Migraine; Substance dependence; Voxel based morphometry

Indexed keywords

ADULT; ANTERIOR CINGULATE; ANTINOCICEPTION; ANXIETY; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSULA; INTERVIEW; MALE; MENTAL DISEASE; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ORBITAL CORTEX; PAIN; PERIAQUEDUCTAL GRAY MATTER; PSYCHIATRIST; VOXEL BASED MORPHOMETRY;

ADULT; ANALGESICS; ANALGESICS, OPIOID; ANXIETY DISORDERS; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HEADACHE DISORDERS, SECONDARY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MENTALLY ILL PERSONS; MIGRAINE DISORDERS; PARIETAL LOBE; PRESCRIPTION DRUG MISUSE; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; THALAMUS;

EID: 84866281631     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2012.665175     Document Type: Article

References (50)

1. Alcaro A, Panksepp J, Witczak J, Hayes DJ, Northoff G. 2010. Is subcortical-cortical midline activity in Depression mediated by glutamate and GABA? A cross-species translational approach. Neurosci Biobehav Rev 34:592-605.
2. Ashburner J, Friston KJ. 2000. Voxel-based morphometry-the methods. Neuroimage 11:805-821.
3. Ashburner J, Friston KJ. 2005. Unified segmentation. Neuroimage 26:839-851. (Pubitemid 40825026)
4. Bergouignan L, Chupin M, Czechowska Y, Kinkingnehun S, Lemogne C, Le Bastard G, et al. 2009. Can voxel based morphometry, manual segmentation and automated segmentation equally DEtect hippocampal volume differences in acute Depression? Neuroimage 45:29-37.
5. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. 2004. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 24:483-490. (Pubitemid 38748030)
6. Bingel U, Quante M, Knab R, Bromm B, Weiller C, Buchel C. 2002. Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 99:313-321. (Pubitemid 35251870)
7. Borsook D, Upadhyay J, Chudler EH, Becerra L. 2010. A key role of the basal ganglia in pain and analgesia-insights gained through human functional imaging. Mol Pain 6:27.
8. Calabresi P, Cupini LM. 2005. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26:62-68. (Pubitemid 40170167)
9. Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, et al. 2006. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009-1013. (Pubitemid 44284910)
10. Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, NicoDEmo M, et al. 2009. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache 49:412-418.
11. Cupini LM, DE Murtas M, Costa C, Mancini M, Eusebi P, Sarchielli P, et al. 2009. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache 49:1005-1013.
12. DaSilva AF, Granziera C, Snyder J, Hadjikhani N. 2007. Thickening in the somatosensory cortex of patients with migraine. Neurology 69:1990-1995. (Pubitemid 350145091)
13. Di Lorenzo C, Di Lorenzo G, Sances G, Ghiotto N, Guaschino E, Grieco GS, et al 2009. Drug consumption in medication overuse headache is influenced by brain-Derived neurotrophic factor Val66Met polymorphism. J Headache Pain 10:349-355.
14. Diener HC, Limmroth V. 2004. Medication-overuse headache: a worldwiDE problem. Lancet Neurol 3:475-483. (Pubitemid 38903098)
15. Dodick DW. 2009. Review of comorbidities and risk factors for the Development of migraine complications (infarct and chronic migraine). Cephalalgia 29(Suppl 3):7-14.
16. Drevets WC, Price JL, Furey ML. 2008. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of Depression. Brain Struct Funct 213:93-118.
17. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, et al 2005. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25:1325-1335. (Pubitemid 40591672)
18. Evers S, Marziniak M. 2010. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391-401.
19. Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CP, et al. 2007. Similarities and differences between chronic migraine and episodic migraine. Headache 47: 65-72. (Pubitemid 46096059)
20. Fuh JL, Wang SJ, Lu SR, Juang KD. 2005. Does medication overuse headache represent a behavior of DEpenDEnce? Pain 119:49-55.
21. Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, et al. 2006. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129:543-550. (Pubitemid 43164376)
22. Granziera C, DaSilva AF, SnyDEr J, Tuch DS, Hadjikhani N. 2006. Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 3, e402.
23. Haber SN, Knutson B. 2010. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35:4-26.
24. International Headache Society. 2004. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 24(Suppl 1):9-160.
25. Jacobsen LK, Giedd JN, Gottschalk C, Kosten TR, Krystal JH. 2001. Quantitative morphology of the caudate and putamen in patients with cocaine DEpenDEnce. Am J Psychiatry 158:486-489. (Pubitemid 32205211)
26. Jensen J, McIntosh AR, Crawley AP, Mikulis DJ, Remington G, Kapur S. 2003. Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40:1251-1257. (Pubitemid 38032799)
27. Knight YE, Goadsby PJ. 2001. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 106:793-800. (Pubitemid 33000183)
28. Mainero C, Boshyan J, Hadjikhani N. 2011. Altered functional MRI resting-state connectivity in periaqueductal gray networks in migraine. Ann Neurol 70:838-845. (http://onlinelibrary. wiley.com/doi/10.1002/ana.22537/ abstract).
29. Maldjian JA, Laurienti PJ, Kraft RA, BurDEtte JH. 2003. An automated method for neuroanatomic and cytoarchitectonic atlasbased interrogation of fMRI data sets. Neuroimage 19: 1233-1239. (Pubitemid 36918259)
30. Mantini D, Caulo M, Feretti A, Romani GL, Tartaro A. 2009. Noxious somatosensory stimulation affects DEfault moDE of brain function. Evidence from functional MR imaging. Radiology 253:797-804.
31. May A. 2007. Neuroimaging: visualising the brain in pain. Neurol Sci 28(Suppl 2):101-107.
32. May A. 2009. Morphing voxels: the hype around structural imaging of headache patients. Brain 132:1419-1425.
33. Obermann M, Nebel K, Schumann C, Holle D, Gizewski ER, Maschke M, et al. 2009. Gray matter changes related to chronic posttraumatic headache. Neurology 73:978-983.
34. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. 2006. New appendix criteria open for a broaDEr concept of chronic migraine. Cephalalgia 26:742-746.
35. Pietrobon D, Striessnig J. 2003. Neurobiology of migraine. Nat Rev Neurosci 4:386-398. (Pubitemid 37280177)
36. Radat F, Sakh D, Lutz G, el Amrani M, Ferreri M, Bousser MG. 1999. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 39:477-480. (Pubitemid 29400298)
37. Radat F, Creach C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, et al. 2005. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25:519-522. (Pubitemid 40896016)
38. Radat F, Creach C, Guegan-Massardier E, Mick G, Guy N, Fabre N, et al. 2008. Behavioral DEpenDEnce in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 48:1026-1036. (Pubitemid 351952107)
39. Radua J, van DEn Heuvel OA, Surguladze S, Mataix-Cols D. 2010. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 67:701-711.
40. Rocca MA, Ceccarelli A, Falini A, Colombo B, Tortorella P, Bernasconi L, et al. 2006. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke 37: 1765-1770. (Pubitemid 44297727)
41. Schmidt-Wilcke T, Leinisch E, Straube A, Kampfe N, Draganski B, Diener HC, et al. 2005. Gray matter DEcrease in patients with chronic tension type headache. Neurology 65:1483-1486. (Pubitemid 41552788)
42. Schmidt-Wilcke T, Leinisch E, Ganssbauer S, Draganski B, Bogdahn U, Altmeppen J, et al. 2006. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain 125:89-97. (Pubitemid 44498967)
43. Schweinhardt P, Kuchinad A, Pukall CF, Bushnell MC. 2008. Increased gray matter DEnsity in young women with chronic vulvar pain. Pain 140:411-419.
44. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the Development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22-33. (Pubitemid 29001829)
45. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. 2001. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56:20-28.
46. Straube A, Pfaffenrath V, Ladwig KH, Meisinger C, Hoffmann W, Fendrich K, et al. 2010. Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study. Cephalalgia 30:207-213.
47. Teutsch S, Herken W, Bingel U, Schoell E, May A. 2008. Changes in brain gray matter due to repetitive painful stimulation. Neuroimage 42:845-849.
48. Younger JW, Shen YF, Goddard G, Mackey SC. 2010. Chronic myofascial temporomandibular pain is associated with neural abnormalities in the trigeminal and limbic systems. Pain 149:222-228.
49. Zhang X, Salmeron BJ, Ross TJ, Geng X, Yang Y, Stein EA. 2011. Factors unDErlying prefrontal and insula structural alterations in smokers. Neuroimage 54:42-48.
50. Zigmond AS, Snaith RP. 1983. The hospital anxiety and Depression scale. Acta Psychiatr Scand 67:361-370. (Pubitemid 13098606)